Freedom Day Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Freedom Day Solutions's VRTX Position: Q3 2026 in Review
Freedom Day Solutions reduced its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q3 2026, selling an estimated $33.8K and leaving 5,868 shares worth $3.07M. The position accounts for 0.67% of the portfolio, ranked #41.
Freedom Day Solutions first reported a position in VRTX in Q2 2020 and has held it in 20 quarters since. 478 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Freedom Day Solutions held 5,868 shares of Vertex Pharmaceuticals worth $3.07M as of Q3 2026.
- Freedom Day Solutions sold 66 Vertex Pharmaceuticals shares in Q3 2026, an estimated $33.8K.
- Vertex Pharmaceuticals made up 0.67% of Freedom Day Solutions's portfolio in Q3 2026, its #41 holding.
- Freedom Day Solutions first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 20 quarters since.
- 478 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Freedom Day Solutions's 13F filing for Q3 2026, filed 20 Oct 2026.